Lyndal K. Hesterberg
Overview
Lyndal K. Hesterberg received an average of $618K in total compensation, including $152K in salary, at Oncocyte Corp from 2015 to 2019.
Source: SEC filings on May 26, 2020, June 18, 2019, and July 27, 2018.
Related executives
We found 16 more executives who work or worked at Oncocyte Corp.
Joshua Riggs
Oncocyte Corp
Chief Executive Officer
Ekkehard Schütz
Oncocyte Corp
Chief Scientific Officer
Anish John
Oncocyte Corp
Chief Financial Officer
James Liu
Oncocyte Corp
Controller and Principal Accounting Officer
Ronald Andrews
Oncocyte Corp
Chief Executive Officer
Gisela Paulsen
Oncocyte Corp
Chief Operating Officer
Douglas Ross
Oncocyte Corp
Chief Scientific Officer
Albert Parker
Oncocyte Corp